An Unusual Cause of Life-Threatening Upper Gastrointestinal Bleeding.
Tian-gang Xiang,Guo-Xing Liu,Tao Li
DOI: https://doi.org/10.1053/j.gastro.2016.05.003
IF: 29.4
2016-01-01
Gastroenterology
Abstract:Question: A 56-year-old man was admitted to our emergency department because of a transient loss of consciousness. He had been suffering from dizziness and melena for two weeks and denied any use of nonsteroidal anti-inflammatory drugs or anticoagulants. At admission, he appeared pale and had mild tachycardia (heart rate 110 bpm). Physical examination revealed pale conjunctiva and abdominal distension without tenderness or palpable abdominal mass. Laboratory tests including tumor markers were unremarkable except for anemia (hemoglobin, 46 g/L [normal, 120–160]; hematocrit, 14.5% [normal, 38%–50%]). After fluid resuscitation, a computed tomography scan was performed and showed a well-defined hypodense tumor originating from the stomach (Figure A, arrow), and the tumor showed slight enhancement in the arterial phase (Figure B, arrow). Endoscopy identified a tumor protruding into the gastric fundus (Figure C) and the patient underwent a laparoscopic and endoscopic cooperative surgery for wedge resection of the stomach. Pathologic examination revealed a submucous gray tumor, 3 × 4.5 cm in size, with areas of focal ulcerations and hemorrhage. Histologic examination revealed that the tumor was composed of spindle-shaped cells and contained <5 per 50 high-power fields mitoses (Figure D). Mutations in exon 9, 11, 13, and 17 of KIT and exon 12 and 18 of PDGFRA were not detected. The patient recovered uneventfully and was followed for 3 months without recurrence. What is the diagnosis of this tumor? Look on page 402 for the answer and see the Gastroenterology web site (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and Images in GI. Immunohistochemical examination (Figure E) showed that the tumor was strongly stained positive for Bcl-2, vimentin, CD34 and CD99, but negative for S100, Dog-1, desmin, CD117, and ALK. The Ki-67 labeling index was 4%. The diagnosis of benign solitary fibrous tumor (SFT) was confirmed. SFT is defined as a ubiquitous mesenchymal tumor of fibroblastic type that shows a prominent hemangiopericytoma-like branching vascular pattern in the 2013 World Health Organization classification scheme.1Fletcher C.D.M. Bridge J.A. Lee J.C. Extrapleural solitary fibrous tumor.in: Fletcher C.D.M. Bridge J.A. Hogendoorn P.C.W. World Health Organization classification of tumours of soft tissue and bone. IARC Press, Lyon2013: 80-82Google Scholar SFT commonly affects adults without sex predominance and can be found at any location of the body, especially in the pleura.2Demicco E.G. Park M.S. Araujo D.M. et al.Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.Mod Pathol. 2012; 25: 1298-1306Crossref PubMed Scopus (296) Google Scholar Although numerous extrathoracic locations, including meninges, orbit, peritoneum, breast, liver, and urogenital organs have been reported, the gastric location is extremely rare. To our knowledge, only 5 cases of SFT of the stomach (SFTS) have been reported in English literature, and our case presents the first case of life-threatening gastrointestinal bleeding caused by SFTS. Although about 10% of SFT behave aggressively and excessive size or involvement of vital structures may lead to local or even paraneoplastic symptoms, SFT usually present as well-delineated, slowly growing, painless masses. Precise diagnosis of SFT is solely based on the accurate interpretation of unique pathologic and immunohistochemical features, and CD34 is now considered to be the characteristic marker of SFT.2Demicco E.G. Park M.S. Araujo D.M. et al.Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.Mod Pathol. 2012; 25: 1298-1306Crossref PubMed Scopus (296) Google Scholar In addition, positive markers of Bcl-2 and CD99, and negative markers of S-100, desmin, and cytokeratins, also contribute to the differential diagnosis of SFT from other mesenchymal tumors, which can not be distinguished by imaging modalities. SFT are categorized as intermediate biological potential with a low risk of metastasis and relatively indolent course. Evidence of benefit of adjuvant therapy is lacking and radical resection remains the best choice of treatment, which may provide a 5-year survival rates of about 90%.2Demicco E.G. Park M.S. Araujo D.M. et al.Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.Mod Pathol. 2012; 25: 1298-1306Crossref PubMed Scopus (296) Google Scholar Hypercellularity, cytologic atypia, tumor necrosis, tumor size, high mitotic rate (≥4 mitoses per 10 high-power fields), and/or infiltrative margins have been recommended as indicator of poor outcome.1Fletcher C.D.M. Bridge J.A. Lee J.C. Extrapleural solitary fibrous tumor.in: Fletcher C.D.M. Bridge J.A. Hogendoorn P.C.W. World Health Organization classification of tumours of soft tissue and bone. IARC Press, Lyon2013: 80-82Google Scholar, 3England D.M. Hochholzer L. McCarthy M.J. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases.Am J Surg Pathol. 1989; 13: 640-658Crossref PubMed Scopus (1125) Google Scholar However, SFT originating from different sites also have different outcome; therefore, the clinical behavior of individual tumor is notoriously difficult to predict.2Demicco E.G. Park M.S. Araujo D.M. et al.Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.Mod Pathol. 2012; 25: 1298-1306Crossref PubMed Scopus (296) Google Scholar As for SFTS, although all the reported cases are histologically proved to be benign, serious evaluation of the biological behavior as well as careful follow-up is still necessary, because the number of SFTS reported to date is too small and long-term follow-up is still lacking. Short-term follow-up may not accurately reflect the malignant potential of SFT; ≤10% metastasis has been reported to occur after 5 years of resection.2Demicco E.G. Park M.S. Araujo D.M. et al.Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.Mod Pathol. 2012; 25: 1298-1306Crossref PubMed Scopus (296) Google Scholar Address correspondence to: Tao Li, Department of General Surgery, Qilu Hospital, Shandong University. e-mail: [email protected]